Hypofractionated Radiation Therapy

Dr. Chirag Shah is a radiation oncologist and director of breast radiation and clinical research in the department of radiation oncology at the Cleveland Clinic. His primary research interests are breast cancer, sarcoma, and innovative radiation treatment schedules, as well as lymphedema. He has participated in numerous clinical trials.

Listen to the podcast to hear Dr. Shah explain:

• the difference between hypofractionated radiation schedules and older, longer radiation schedules, as well as why accelerated schedules were created
• the benefits and possible risks of a hypofractionated radiation schedule
• how to advocate for yourself if your radiation oncologist doesn’t recommend a hypofractionated schedule